ZIM LABORATORIES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 104.3 INR | +0.34% |
|
-6.50% | -9.50% |
| May. 14 | Zim Laboratories' Consolidated Profit Climbs in Fiscal Q4; Shares Slide 5% | MT |
| May. 13 | ZIM Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
ZIM Laboratories Limited is a pharmaceutical company. The Company develops, manufactures and supplies oral, solid differentiated generic pharmaceutical formulations and pre-formulation intermediaries (PFI) in various therapeutic segments. Its delivery solutions cover product conceptualization product development, filing for registration, manufacture, and supply of various pharmaceutical formulations. It is developing products in various therapeutic segments like, central nervous system, anti-biotic and anti-infective, gastrointestinal, cardiovascular, analgesic/pain management, urology and vitamins, minerals, and dietary supplements. Its technological capabilities include drug release modification, solubility and stability enhancement, taste masking and dosage form transformation. Its product offerings include finished formulations and pre-formulations intermediates, which include granules, pellets, taste-masked powders, dry suspensions, tablets, capsules, and oral thin films.
Sector
Pharmaceuticals
Calendar
2024-08-05
- Q1 2025 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -9.50% | 60.93M | |
| +16.31% | 42.32B | |
| +16.11% | 21.29B | |
| +19.33% | 15.29B | |
| +18.71% | 14.36B | |
| +52.78% | 12.81B | |
| -0.05% | 6.79B | |
| -12.40% | 6.58B | |
| -8.87% | 5.73B | |
| +14.28% | 5.51B |
- Stock Market
- Equities
- ZIMLAB Stock
- News ZIM Laboratories Limited
- ZIM Laboratories Issues Over 32 Million Bonus Shares
